Extrapolating In Vitro Results to Predict Human Toxicity

[1]  Guido Sanguinetti,et al.  Hybrid regulatory models: a statistically tractable approach to model regulatory network dynamics , 2013, Bioinform..

[2]  Steffen Borchers,et al.  Integrating Cellular Metabolism into a Multiscale Whole-Body Model , 2012, PLoS Comput. Biol..

[3]  Michael L Shuler,et al.  Incorporation of 3T3‐L1 Cells To Mimic Bioaccumulation in a Microscale Cell Culture Analog Device for Toxicity Studies , 2008, Biotechnology progress.

[4]  Bas J Blaauboer,et al.  Biokinetic Modeling and in Vitro–in Vivo Extrapolations , 2010, Journal of toxicology and environmental health. Part B, Critical reviews.

[5]  D. Ingber,et al.  Reconstituting Organ-Level Lung Functions on a Chip , 2010, Science.

[6]  Malcolm Rowland,et al.  Physiologically-based pharmacokinetics in drug development and regulatory science. , 2011, Annual review of pharmacology and toxicology.

[7]  Bas J Blaauboer,et al.  Application of integrated transcriptomic, proteomic and metabolomic profiling for the delineation of mechanisms of drug induced cell stress. , 2013, Journal of proteomics.

[8]  Frédéric Y Bois,et al.  Physiologically based modelling and prediction of drug interactions. , 2010, Basic & clinical pharmacology & toxicology.

[9]  M. Jamei,et al.  PBPK modelling of inter-individual variability in the pharmacokinetics of environmental chemicals. , 2010, Toxicology.

[10]  H Seibert,et al.  Factors influencing nominal effective concentrations of chemical compounds in vitro: medium protein concentration. , 2002, Toxicology in vitro : an international journal published in association with BIBRA.

[11]  K. Jensen,et al.  Cells on chips , 2006, Nature.

[12]  Marilyn E. Morris,et al.  Prediction of Biliary Excretion in Rats and Humans Using Molecular Weight and Quantitative Structure–Pharmacokinetic Relationships , 2009, The AAPS Journal.

[13]  Michael L Shuler,et al.  A novel system for evaluation of drug mixtures for potential efficacy in treating multidrug resistant cancers , 2009, Biotechnology and bioengineering.

[14]  Weihsueh A. Chiu,et al.  Addressing Human Variability in Next-Generation Human Health Risk Assessments of Environmental Chemicals , 2012, Environmental health perspectives.

[15]  J Wakefield,et al.  Errors‐in‐Variables in Joint Population Pharmacokinetic/Pharmacodynamic Modeling , 2001, Biometrics.

[16]  Sunwoo Park,et al.  Predictions of Hepatic Disposition Properties Using a Mechanistically Realistic, Physiologically Based Model , 2008, Drug Metabolism and Disposition.

[17]  Hans V Westerhoff,et al.  Multiscale modelling approach combining a kinetic model of glutathione metabolism with PBPK models of paracetamol and the potential glutathione-depletion biomarkers ophthalmic acid and 5-oxoproline in humans and rats. , 2013, Integrative biology : quantitative biosciences from nano to macro.

[18]  Frédéric Y. Bois,et al.  A Computational Model to Predict Rat Ovarian Steroid Secretion from In Vitro Experiments with Endocrine Disruptors , 2013, PloS one.

[19]  Qiang Zhang,et al.  Dose Response Relationship in Anti-Stress Gene Regulatory Networks , 2006, PLoS Comput. Biol..

[20]  Denis Noble,et al.  Editorial: Computational modelling of cell & tissue processes & function , 2004, Journal of Molecular Histology.

[21]  Zheng Li,et al.  Large-scale dynamic gene regulatory network inference combining differential equation models with local dynamic Bayesian network analysis , 2011, Bioinform..

[22]  Bas J Blaauboer,et al.  The use of in vitro toxicity data and physiologically based kinetic modeling to predict dose-response curves for in vivo developmental toxicity of glycol ethers in rat and man. , 2010, Toxicological sciences : an official journal of the Society of Toxicology.

[23]  N. Quignot.  Modeling bioavailability to organs protected by biological barriers , 2013, In Silico Pharmacology.

[24]  Valérie Zuang,et al.  Alternative (non-animal) methods for cosmetics testing: current status and future prospects—2010 , 2011, Archives of Toxicology.

[25]  Samir Mitragotri,et al.  Mathematical models of skin permeability: an overview. , 2011, International journal of pharmaceutics.

[26]  R L Binder,et al.  Xenobiotic metabolism gene expression in the EpiDermin vitro 3D human epidermis model compared to human skin. , 2010, Toxicology in vitro : an international journal published in association with BIBRA.

[27]  D. Nakai,et al.  Evaluation of the protein binding ratio of drugs by a micro-scale ultracentrifugation method. , 2004, Journal of pharmaceutical sciences.

[28]  Wolfgang Weiss,et al.  A Computational Systems Biology Software Platform for Multiscale Modeling and Simulation: Integrating Whole-Body Physiology, Disease Biology, and Molecular Reaction Networks , 2011, Front. Physio..

[29]  Robert Barouki,et al.  A comparison of two human cell lines and two rat gonadal cell primary cultures as in vitro screening tools for aromatase modulation. , 2012, Toxicology in vitro : an international journal published in association with BIBRA.

[30]  Harvey J Clewell,et al.  Physiologically based pharmacokinetic/toxicokinetic modeling. , 2012, Methods in molecular biology.

[31]  Kairui Feng,et al.  The Simcyp® Population-based ADME Simulator , 2009 .

[32]  D. Mills,et al.  A quantitative structure–activity relationship (QSAR) study of dermal absorption using theoretical molecular descriptors , 2007, SAR and QSAR in environmental research.

[33]  Fabian J. Theis,et al.  Gaussian graphical modeling reconstructs pathway reactions from high-throughput metabolomics data , 2011, BMC Systems Biology.

[34]  Beat Neuenschwander,et al.  Combining MCMC with ‘sequential’ PKPD modelling , 2009, Journal of Pharmacokinetics and Pharmacodynamics.

[35]  Robert J Kavlock,et al.  Computational toxicology--a state of the science mini review. , 2008, Toxicological sciences : an official journal of the Society of Toxicology.

[36]  Harvey J Clewell,et al.  Relative impact of incorporating pharmacokinetics on predicting in vivo hazard and mode of action from high-throughput in vitro toxicity assays. , 2013, Toxicological sciences : an official journal of the Society of Toxicology.

[37]  Yasuyuki Sakai,et al.  Kinetic modelling of in vitro cell-based assays to characterize non-specific bindings and ADME processes in a static and a perfused fluidic system. , 2011, Toxicology letters.

[38]  G. de Fabritiis,et al.  Complete reconstruction of an enzyme-inhibitor binding process by molecular dynamics simulations , 2011, Proceedings of the National Academy of Sciences.

[39]  Frédéric Y. Bois,et al.  Population-Based Pharmacokinetic Modeling and Simulation , 2012 .

[40]  A. Guillouzo,et al.  Running title page Running title : Functional stability of CYP P 450 enzymes in HepaRG cells , 2009 .

[41]  W. Slob,et al.  An improved model to predict physiologically based model parameters and their inter-individual variability from anthropometry , 2012, Critical reviews in toxicology.

[42]  H Seibert,et al.  Factors influencing nominal effective concentrations of chemical compounds in vitro: cell concentration. , 2001, Toxicology in vitro : an international journal published in association with BIBRA.

[43]  Hiroaki Kitano,et al.  The systems biology markup language (SBML): a medium for representation and exchange of biochemical network models , 2003, Bioinform..

[44]  Sean Ekins,et al.  A hybrid approach to advancing quantitative prediction of tissue distribution of basic drugs in human. , 2011, Toxicology and applied pharmacology.

[45]  F Y Bois,et al.  Statistical issues in toxicokinetic modeling: a bayesian perspective. , 2000, Environmental health perspectives.

[46]  L. Tremaine,et al.  Impact of drug transporter pharmacogenomics on pharmacokinetic and pharmacodynamic variability – considerations for drug development , 2012, Expert opinion on drug metabolism & toxicology.

[47]  Sean H. J. Kim,et al.  At the Biological Modeling and Simulation Frontier , 2009, Pharmaceutical Research.

[48]  Masaru Tomita,et al.  A general computational model of mitochondrial metabolism in a whole organelle scale , 2004, Bioinform..

[49]  Markus P. Schlaich,et al.  Change in Sympathetic Nerve Firing Pattern Associated with Dietary Weight Loss in the Metabolic Syndrome , 2011, Front. Physio..

[50]  Robert Barouki,et al.  Quantification of steroids and endocrine disrupting chemicals in rat ovaries by LC-MS/MS for reproductive toxicology assessment , 2012, Analytical and Bioanalytical Chemistry.

[51]  D. Musson,et al.  Investigation of high-throughput ultrafiltration for the determination of an unbound compound in human plasma using liquid chromatography and tandem mass spectrometry with electrospray ionization. , 2006, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[52]  B. Kowtharapu,et al.  Peritubular cells may modulate Leydig cell-mediated testosterone production through a nonclassic pathway. , 2012, Fertility and sterility.

[53]  Frédéric Y. Bois,et al.  GNU MCSim: Bayesian statistical inference for SBML-coded systems biology models , 2009, Bioinform..

[54]  Bas J Blaauboer,et al.  Evaluation of research activities and research needs to increase the impact and applicability of alternative testing strategies in risk assessment practice. , 2011, Regulatory toxicology and pharmacology : RTP.

[55]  Harvey J Clewell,et al.  Quantitative in vitro to in vivo extrapolation of cell-based toxicity assay results , 2012, Critical reviews in toxicology.

[56]  R. Melnick,et al.  Purpose and guidelines for toxicokinetic studies within the National Toxicology Program. , 1997, Environmental health perspectives.

[57]  A. Gelman,et al.  Physiological Pharmacokinetic Analysis Using Population Modeling and Informative Prior Distributions , 1996 .

[58]  Josep Roca,et al.  Reactive Oxygen Species Production by Forward and Reverse Electron Fluxes in the Mitochondrial Respiratory Chain , 2011, PLoS Comput. Biol..

[59]  George Loizou,et al.  Toxicokinetics as a key to the integrated toxicity risk assessment based primarily on non-animal approaches. , 2013, Toxicology in vitro : an international journal published in association with BIBRA.

[60]  Trey Ideker,et al.  Hot spots for modulating toxicity identified by genomic phenotyping and localization mapping. , 2004, Molecular cell.

[61]  Rémy Beaudouin,et al.  A stochastic whole-body physiologically based pharmacokinetic model to assess the impact of inter-individual variability on tissue dosimetry over the human lifespan. , 2010, Regulatory toxicology and pharmacology : RTP.

[62]  Nigel J Waters,et al.  Validation of a rapid equilibrium dialysis approach for the measurement of plasma protein binding. , 2008, Journal of pharmaceutical sciences.

[63]  Vera Fiserova-Bergerova,et al.  Determination and prediction of tissue-gas partition coefficients , 1986, International archives of occupational and environmental health.

[64]  Harvey J Clewell,et al.  Kinetic modeling of β-chloroprene metabolism: Probabilistic in vitro-in vivo extrapolation of metabolism in the lung, liver and kidneys of mice, rats and humans. , 2012, Toxicology in vitro : an international journal published in association with BIBRA.

[65]  Han van de Waterbeemd,et al.  High-throughput and in silico techniques in drug metabolism and pharmacokinetics. , 2002 .

[66]  H. Westerhoff,et al.  Systems biology tools for toxicology , 2012, Archives of Toxicology.

[67]  J. Valentin.  Basic anatomical and physiological data for use in radiological protection: reference values , 2002, Annals of the ICRP.

[68]  Jong Hwan Sung,et al.  Integration of in silico and in vitro platforms for pharmacokinetic–pharmacodynamic modeling , 2010, Expert opinion on drug metabolism & toxicology.

[69]  T J Maguire,et al.  Design and application of microfluidic systems for in vitro pharmacokinetic evaluation of drug candidates. , 2009, Current drug metabolism.

[70]  D. Beard,et al.  Use of partition coefficients in flow-limited physiologically-based pharmacokinetic modeling , 2012, Journal of Pharmacokinetics and Pharmacodynamics.

[71]  Aaron Sin,et al.  Development of a Microscale Cell Culture Analog To Probe Naphthalene Toxicity , 2008, Biotechnology progress.

[72]  J. Dorne,et al.  Metabolism, variability and risk assessment. , 2010, Toxicology.

[73]  P. Annaert,et al.  Sandwich-cultured hepatocytes: utility for in vitro exploration of hepatobiliary drug disposition and drug-induced hepatotoxicity , 2013, Expert opinion on drug metabolism & toxicology.

[74]  Elaina M Kenyon,et al.  Kinetic modeling of beta-chloroprene metabolism: II. The application of physiologically based modeling for cancer dose response analysis. , 2004, Toxicological sciences : an official journal of the Society of Toxicology.